Inhibition of nitric oxide synthase prevents α7 nicotinic receptor-mediated restoration of inhibitory auditory gating in rat hippocampus

被引:25
作者
Adams, CE [1 ]
Stevens, KE
Kem, WR
Freedman, R
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Psychiat, Denver, CO 80262 USA
[2] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
关键词
nitric oxide; schizophrenia; nicotinic receptors; inhibition; hippocampus;
D O I
10.1016/S0006-8993(00)02677-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The hippocampus rapidly inhibits its response to repetitive auditory stimulation, an example of an auditory sensory gating mechanism involved in human psychopathology. The neuronal basis of this inhibitory gating mechanism has been investigated in rats. Activation of the alpha 7 nicotinic receptor is required. alpha 7 nicotinic receptor activation also releases nitric oxide in the hippocampus and blockade of nitric oxide synthase reduces inhibitory gating of auditory response. There has not been a direct demonstration that blockade of nitric oxide synthase specifically prevents alpha 7 nicotinic receptor activation of the inhibition of auditory response. Therefore, the goal of the present study was to determine whether this functional effect of alpha 7 receptor activation requires release of nitric oxide. Lesions of the fimbria-fornix disrupt auditory gating by preventing cholinergic stimulation of the hippocampus. Following recovery from this surgery, rats were administered 3-(2,4-dimethoxybenzylidene) anabaseine (DMXB-A; 10 mg/kg, sc), an agonist at the alpha 7 receptor. DMXB-A restored auditory gating in the fimbria-fornix-lesioned rats, indicating that activation of the alpha 7 nicotinic receptor alone is sufficient to restore auditory gating following lesions of the fimbria-fornix. However, intracerebroventricular infusion of N-omega-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase, blocked the DMXB-A-mediated restoration of auditory gating; infusion of the inactive D-enantiomer did not. Restoration of auditory gating by DMXB-A in the fimbria-fornix-lesioned rats was blocked by intracerebroventricular infusion of alpha-bungarotoxin, but not by mecamylamine or dihydro-beta-erythroidine. Together, these data support the hypothesis that nitric oxide mediates alpha 7 nicotinic receptor activation of gating of auditory response in rat hippocampus. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 39 条
[1]   Nicotinic antagonist α-bungarotoxin binding to rat hippocampal neurons containing nitric oxide synthase [J].
Adams, CE ;
Freedman, R .
BRAIN RESEARCH, 1997, 776 (1-2) :111-116
[2]  
Adams CE, 1998, J PHARMACOL EXP THER, V287, P760
[3]  
ADLER LE, 1993, AM J PSYCHIAT, V150, P1856
[4]  
AKBARIAN S, 1993, ARCH GEN PSYCHIAT, V50, P178
[5]   NICOTINIC RECEPTOR FUNCTION IN THE MAMMALIAN CENTRAL-NERVOUS-SYSTEM [J].
ALBUQUERQUE, EX ;
PEREIRA, EFR ;
CASTRO, NG ;
ALKONDON, M ;
REINHARDT, S ;
SCHRODER, H ;
MAELICKE, A .
DIVERSITY OF INTERACTING RECEPTORS, 1995, 757 :48-72
[6]   The inhibitory effects of N omega-nitro-L-arginine methyl ester on nitric oxide synthase activity vary among brain regions in vivo but not in vitro [J].
Ayers, NA ;
Kapas, L ;
Krueger, JM .
NEUROCHEMICAL RESEARCH, 1997, 22 (01) :81-86
[7]   AUDITORY SENSORY GATING IN THE RAT HIPPOCAMPUS - MODULATION BY BRAIN-STEM ACTIVITY [J].
BICKFORD, PC ;
LUNTZLEYBMAN, V ;
FREEDMAN, R .
BRAIN RESEARCH, 1993, 607 (1-2) :33-38
[8]   Restoration of sensory gating of auditory evoked response by nicotine in fimbria-fornix lesioned rats [J].
Bickford, PC ;
Wear, KD .
BRAIN RESEARCH, 1995, 705 (1-2) :235-240
[9]  
Bredt David S., 1995, P1, DOI 10.1016/B978-012721985-1/50003-4
[10]   Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo [J].
Briggs, CA ;
Anderson, DJ ;
Brioni, JD ;
Buccafusco, JJ ;
Buckley, MJ ;
Campbell, JE ;
Decker, MW ;
DonnellyRoberts, D ;
Elliott, RL ;
Gopalakrishnan, M ;
Holladay, MW ;
Hui, YH ;
Jackson, WJ ;
Kim, DJB ;
Marsh, KC ;
ONeill, A ;
Prendergast, MA ;
Ryther, KB ;
Sullivan, JP ;
Arneric, SP .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (1-2) :231-241